GB1417030A - Lactamimide derivatives - Google Patents

Lactamimide derivatives

Info

Publication number
GB1417030A
GB1417030A GB5521173A GB5521173A GB1417030A GB 1417030 A GB1417030 A GB 1417030A GB 5521173 A GB5521173 A GB 5521173A GB 5521173 A GB5521173 A GB 5521173A GB 1417030 A GB1417030 A GB 1417030A
Authority
GB
United Kingdom
Prior art keywords
formula
alkyl
pharmaceutically acceptable
acid addition
addition salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5521173A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Inc
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of GB1417030A publication Critical patent/GB1417030A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
GB5521173A 1973-01-05 1973-11-28 Lactamimide derivatives Expired GB1417030A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00321160A US3816457A (en) 1973-01-05 1973-01-05 Lactamimide derivatives

Publications (1)

Publication Number Publication Date
GB1417030A true GB1417030A (en) 1975-12-10

Family

ID=23249450

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5521173A Expired GB1417030A (en) 1973-01-05 1973-11-28 Lactamimide derivatives

Country Status (9)

Country Link
US (1) US3816457A (enExample)
JP (1) JPS5647186B2 (enExample)
AU (1) AU469726B2 (enExample)
CA (1) CA1018170A (enExample)
DE (1) DE2365006A1 (enExample)
FR (1) FR2213063B1 (enExample)
GB (1) GB1417030A (enExample)
IL (1) IL43704A (enExample)
ZA (1) ZA738704B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0253502A3 (en) * 1986-07-16 1990-04-11 Imperial Chemical Industries Plc Tertiary amine compounds

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4153235A (en) * 1973-08-09 1979-05-08 Richardson-Merrell Inc. Substituted cycloalkyl lactamimides
JPS5444660A (en) * 1977-08-29 1979-04-09 Yamanouchi Pharmaceut Co Ltd Heterocyclic compound and its preparation
US5010072A (en) * 1988-06-28 1991-04-23 Merrell Dow Pharmaceuticals Inc. Lactamimides as calcium antagonists
US5198433A (en) * 1988-06-28 1993-03-30 Merrell Dow Pharmaceuticals Inc. Lactamimides as calcium antagonists
US5082837A (en) * 1988-06-28 1992-01-21 Merrell Dow Pharmaceuticals Lactamimides as calcium antagonists
KR100342275B1 (ko) * 1993-10-21 2002-12-05 지.디. 썰 엘엘씨 산화질소신타제저해제로서유용한아미디노유도체
ATE246678T1 (de) * 1995-04-20 2003-08-15 Searle & Co Zyclische amidino mittel als stickstoffoxid- synthase inhibitoren
US5981556A (en) * 1997-07-22 1999-11-09 G.D. Searle & Co. 1,3-diazolino and 1,3-diazolidino heterocycles as useful nitric oxide synthase inhibitors
AU4821799A (en) 1998-06-10 1999-12-30 G.D. Searle & Co. Heterobicyclic and tricyclic nitric oxide synthase inhibitors
US6344473B1 (en) 2000-08-07 2002-02-05 G.D. Searle & Co. Imidazoles useful as nitric oxide synthase inhibitors
DE10125145A1 (de) * 2001-05-22 2002-11-28 Gruenenthal Gmbh Substituierte C-Furan-2-yl-methylamin- und C-Thiophen-2-yl-methylamin-Derivate
USD825997S1 (en) 2018-03-22 2018-08-21 Remson Concepts, Inc Stackable serving tray
USD835467S1 (en) 2018-07-23 2018-12-11 Remson Concepts, Inc. Stackable serving tray

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA722407B (en) * 1971-05-13 1973-01-31 Richardson Merrell Inc Substituted cycloalkyl lactamimides

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0253502A3 (en) * 1986-07-16 1990-04-11 Imperial Chemical Industries Plc Tertiary amine compounds

Also Published As

Publication number Publication date
ZA738704B (en) 1974-09-25
US3816457A (en) 1974-06-11
JPS4995966A (enExample) 1974-09-11
DE2365006A1 (de) 1974-07-18
FR2213063A1 (enExample) 1974-08-02
IL43704A0 (en) 1974-03-14
JPS5647186B2 (enExample) 1981-11-07
FR2213063B1 (enExample) 1977-03-11
IL43704A (en) 1976-11-30
CA1018170A (en) 1977-09-27
AU6250973A (en) 1975-05-15
AU469726B2 (en) 1976-02-19

Similar Documents

Publication Publication Date Title
GB1417030A (en) Lactamimide derivatives
ES8107185A1 (es) Procedimiento para preparar piperidinas y pirrolidinas sus- tituidas
IT1254373B (it) Eteroprostanoidi, procedimento per la loro preparazione e loro impiegoterapeutico.
ES358444A1 (es) Procedimiento para la obtencion de derivados de la fenil-a-cetil-guanidina.
ES8306755A1 (es) "procedimiento para la preparacion de nuevos derivados de azepina".
GB1488692A (en) Pyrazolo(3,4,6)quinolines
GB1410755A (en) Tricyclic substituted aminoalcohols and the preparation thereof
GB1411583A (en) Aminophenyl-substituted alkyl-heterocyclic derivatives and processes for producing them
GB1456627A (en) Pyridobenzodiazepinones
GB1369999A (en) Monomethyl-amino-triidobenzene compounds for use as x-ray shading agents
GB1413455A (en) Alpha-cycloalkylbenzyl lactamimides
GB1460071A (en) Tetrahydronaphthyloxy-amines and related compounds
GB1434147A (en) Tripeptides
GB1436307A (en) Diaromatic o-aminoalkyl-oximes
GB1421058A (en) Dibenzocycloheptenyl lactamimides
GB1494560A (en) 4-aryl-5-aminoalkyl-4-thiazolin-2-ones and their preparation
GB1469430A (en) Daunomycin derivatives
GB1449078A (en) Phenoxyethylamine derivatives
GB1268469A (en) Halomethylquinolylamino-benzamides
GB1307498A (en) 5-phenylbenzomorphan derivatives salts thereof and processes of making them
GB1454737A (en) Sulphonylcarbamoyl derivatives
GB1514225A (en) Paracetamol derivatives
GB1509536A (en) Anti-malarial compositions
GB1299566A (en) Bis-basic ethers of 2,6- and 2,7-dihydroxyanthraquinones
GB1420780A (en) Medicinal preparation of treatment of malignant neoplasms mostly hemoblastoses and chorionepithelioma

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee